Gina Mazza

22PUBLICATIONS
112CO-AUTHORS
Clinical psychologyEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Panel data analysisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 28, 2026
Psychometric Evaluation of the PRO-CTCAE Average Composite Score: Reliability, Responsiveness, Known-Groups Validity, and Sensitivity to Group Differences.

|May 12, 2026
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39).

|Jan 26, 2026
Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer.

Bradley J Stish, Gina L Mazza, Jones T Nauseef

|Nov 13, 2025
Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden.

Minji K Lee, Sandra A Mitchell, Ethan Basch

|Sep 03, 2025
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202).

Emily K Bergsland, Susan Geyer, Timothy R Asmis

|Aug 19, 2025
Self-Reported Adherence to Cancer Therapy: Development and Validation of the Domains of Subjective Extent of Nonadherence-Cancer Measure.

Yashasvini Sampathkumar, Corrine I Voils, Gina L Mazza

Pageof 4

Frequent Collaborators

5 joint publications

Amylou C Dueck

5 joint publications

Ethan Basch

5 joint publications

Allison M Deal

4 joint publications

Lauren Rogak